POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (6.15.2021, 11:19am CEST, WHO):   U.S. 8,197    India 70,421    Brazil 37,948    France 2,850    Turkey 5,012    Russia 13,721    The United Kingdom 7,319    Italy 1,390    Argentina 13,043    Columbia 28,519    Iran 10,715    Mexico 1,707    Peru 2,566    Indonesia 8,189    South Africa 7,657    The Netherlands 1,066    Chile 6,190    Canada 1,120    Philippines 6,426    Iraq 5,040    Pakistan 1,019    Bangladesh 3,050    Japan 1,076    Malaysia 4,949    Nepal 2,049    United Arab Emirates 1,837    Saudi Arabia 1,109    Bolivia 1,607    Paraguay 1,786    Panama 1,573    Tunisia 1,316    Uruguay 2,043    Kuwait 1,563    Venezuela 1,377    Oman 1,806    Sri Lanka 2,284    Thailand 3,355    Cuba 1,349    Zambia 1,414    Afghanistan 1,814    Mongolia 2,263    Uganda 1,727    China 206    Singapore 25    New Zealand 1    Australia 14    South Korea 374   

Germs with unusual antibiotic resistance widespread in U.S.

Staff Writer |
Health departments working with CDC's Antibiotic Resistance (AR) Lab Network found more than 220 instances of germs with "unusual" antibiotic resistance genes in the United States last year, according to a CDC Vital Signs report.

Article continues below




erms with unusual resistance include those that cannot be killed by all or most antibiotics, are uncommon in a geographic area or the U.S., or have specific genes that allow them to spread their resistance to other germs.

Rapid identification of the new or rare threats is the critical first step in CDC's containment strategy to stop the spread of antibiotic resistance (AR).

When a germ with unusual resistance is detected, facilities can quickly isolate patients and begin aggressive infection control and screening actions to discover, reduce, and stop transmission to others.

"CDC's study found several dangerous pathogens, hiding in plain sight, that can cause infections that are difficult or impossible to treat," said CDC Principal Deputy Director Anne Schuchat, M.D.

"It's reassuring to see that state and local experts, using our containment strategy, identified and stopped these resistant bacteria before they had the opportunity to spread."

The CDC containment strategy calls for rapid identification of resistance, infection control assessments, testing patients without symptoms who may carry and spread the germ, and continued infection control assessments until spread is stopped.

The strategy requires a coordinated response among health care facilities, labs, health departments and CDC through the AR Lab Network.

Health departments using the approach have conducted infection control assessments and colonization screenings within 48 hours of finding unusual resistance and have reported no further transmission during follow-up over several weeks.

The strategy complements foundational CDC efforts, including improving antibiotic use and preventing new infections, and builds on existing detection and response infrastructure.

New data suggest that the containment strategy can prevent thousands of difficult-to-treat or potentially untreatable infections, including high-priority threats such as Candida auris and carbapenem-resistant Enterobacteriaceae (CRE).

Germs will continuously find ways to resist new and existing antibiotics; stopping new resistance from developing is not currently possible.

Recent, nationwide infrastructure investments in laboratories, infection control, and response are enabling tailored, rapid, and aggressive investigations to keep resistance from spreading in health care settings.

One in four germ samples sent to the AR Lab Network for testing had a special genes that allow them to spread their resistance to other germs.

Further investigation in facilities with unusual resistance revealed that about one in 10 screening tests, from patients without symptoms, identified a hard-to-treat germ that spreads easily. This means the germ could have spread undetected in that health care facility.

For CRE alone, estimates show that the containment strategy would prevent as many as 1,600 new infections in three years in a single state - a 76 percent reduction.


What to read next

EFSA report unveils new resistant bacteria threats
Scientists discern new antibiotics resistance mechanism to peptide antibiotics
Bacteria 'sleep' to survive antibiotic treatments and then attack